Literature DB >> 31825158

Providing more evidence on LZTR1 variants in Noonan syndrome patients.

Josefina Chinton1, Victoria Huckstadt2, Mafalda Mucciolo3, Francesca Lepri3, Antonio Novelli3, Luis Pablo Gravina1, María Gabriela Obregon2.   

Abstract

Noonan syndrome (NS, OMIM 163950) is a common autosomal dominant RASopathy caused mainly by gain-of-function germline pathogenic variants in genes involved in the RAS/MAPK signaling pathway. LZTR1 gene has been associated with both dominant and recessive NS. Here, we present seven patients with NS and variants in the LZTR1 gene from seven unrelated families, 14 individuals in total. The detection rAte of LZTR1 variants in our NS cohort was 4% similar to RAF1 and KRAS genes, indicating that variants in this gene might be frequent among our population. Three different variants were detected, c.742G>A (p.Gly248Arg), c.360C>A (p.His120Gln), and c.2245T>C (p.Tyr749His). The pathogenic variant c.742G>A (p.Gly248Arg) was found in five/seven patients. In our cohort 50% of patients presented heart defects and neurodevelopment delay or learning disabilities, short stature was present in 21% of them and one patient had acute lymphoblastic leukemia. This study broadens the spectrum of variants in the LZTR1 gene and provides increased knowledge of the clinical phenotypes observed in Argentinean NS patients.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990LZTR1; Argentina; Noonan syndrome; RASopathies

Mesh:

Substances:

Year:  2019        PMID: 31825158     DOI: 10.1002/ajmg.a.61445

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  A Chinese family with Noonan syndrome caused by a heterozygous variant in LZTR1: a case report and literature review.

Authors:  Xiu Zhao; Zhuoguang Li; Li Wang; Zhangzhang Lan; Feifei Lin; Wenyong Zhang; Zhe Su
Journal:  BMC Endocr Disord       Date:  2021-01-06       Impact factor: 2.763

2.  Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia.

Authors:  Suvi P M Douglas; Atte K Lahtinen; Jessica R Koski; Lilli Leimi; Mikko A I Keränen; Minna Koskenvuo; Caroline A Heckman; Kirsi Jahnukainen; Esa Pitkänen; Ulla Wartiovaara-Kautto; Outi Kilpivaara
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

3.  Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins.

Authors:  Javier-Fernando Montero-Bullón; Óscar González-Velasco; María Isidoro-García; Jesus Lacal
Journal:  Orphanet J Rare Dis       Date:  2021-07-06       Impact factor: 4.123

4.  Clinical Genetic Risk Variants Inform a Functional Protein Interaction Network for Tetralogy of Fallot.

Authors:  Miriam S Reuter; Rajiv R Chaturvedi; Rebekah K Jobling; Giovanna Pellecchia; Omar Hamdan; Wilson W L Sung; Thomas Nalpathamkalam; Pratyusha Attaluri; Candice K Silversides; Rachel M Wald; Christian R Marshall; Simon G Williams; Bernard D Keavney; Bhooma Thiruvahindrapuram; Stephen W Scherer; Anne S Bassett
Journal:  Circ Genom Precis Med       Date:  2021-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.